Key result
Propafenone reduces ambulatory arrhythmias and abolishes inducible VT in ~57% of patients with LV dysfunction.
Why the study?
Does propafenone reduce ventricular tachyarrhythmias in patients with impaired left ventricular function?
Does propafenone reduce ventricular tachyarrhythmias in patients with impaired left ventricular function?
In a small cohort, propafenone reduced ventricular tachyarrhythmias without significantly changing ejection fraction, though modern guidelines now strictly contraindicate Class IC antiarrhythmics in patients with structural heart disease or impaired LV function.
Answers are grounded in this paper and cite their sources.
Propafenone appeared to suppress arrhythmias without LVEF change in this small series; leaves open any role amid current Class IC contraindications in structural heart disease.
The combined occurrence of left ventricular dysfunction and ‐ventricular tachyarrhythmias portends a high annual mortality. Anti arrhythmic drugs can ameliorate ventricular arrhythmia and may reduce the risk of sudden cardiac death. We administered propafenone to 15 patients with ventricular tachyarrhythmias and left ventricular ejection fractions 40%. Propafenone significantly reduced isolated ventricular premature depolarizations, couplets, and ventricular tachycardia on ambulatory monitoring. Propafenone eliminated all exercise provocable ventricular tachycardia. Propafenone additionally abolished ventricular tachycardia inducible by programmed stimulation in 4 of 7 patients. In 8 patients studied before and during therapy, there was no significant change in left ventricular ejection fraction as determined by nuclear ventriculography. Propafenone was discontinued in 4 patients due to side effects. Seven patients receiving continuing propafenone therapy remain alive with only one patient suffering arrhythmia recurrence. Propafenone is an effective drug for the management of ventricular tachyarrhythmias and may be used for patients with impaired left ventricular function.
No takes yet. Share an insight, caveat, or question.
Brodsky et al. (1986) studied Ventricular tachyarrhythmias with impaired left ventricular function (n=15). Propafenone was evaluated on Ventricular arrhythmias on ambulatory monitoring. Propafenone significantly reduced ventricular arrhythmias on ambulatory monitoring and abolished inducible ventricular tachycardia in 4 of 7 patients with impaired left ventricular function.
Synapse has enriched 10 related papers. Consider them for comparative context: